AGR2 Predicts Tamoxifen Resistance in Postmenopausal Breast Cancer Patients

Endocrine resistance is a significant problem in breast cancer treatment. Thus identification and validation of novel resistance determinants is important to improve treatment efficacy and patient outcome. In our work, AGR2 expression was determined by qRT-PCR in Tru-Cut needle biopsies from tamoxif...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Hrstka, Roman, Brychtova, Veronika, Fabian, Pavel, Vojtesek, Borivoj, Svoboda, Marek
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2013
Teme:
Clinical Study
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3776368/
https://ncbi.nlm.nih.gov/pubmed/24167368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/761537
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items